Table 2.

Cost effectiveness of HCC surveillance strategies with base case inputs

	Average Overall Cost (USD)	Incremental Cost (USD)	Average Overall QALYs	Incremental QALYs	Cost per incremental QALY
US with AFP	1,254,173.20	0.00	6.02	0.00	-
US Alone	1,257,879.04	3,705.84	6.00	−0.02	Dominated
No surveillance	1,266,358.65	12,185.45	5.98	−0.04	Dominated
Maximum cross-sectional imaging before diagnosis
US with AFP	1,256,329.35	0.00	6.02	0.00	-
US Alone	1,260,328.23	3,998.88	5.99	−0.03	Dominated
No surveillance	1,268,173.63	11,844.29	5.99	−0.03	Dominated
Minimum cross-sectional imaging before diagnosis
US with AFP	1,251,775.31	0.00	6.03	0.00	-
US Alone	1,254,641.51	2,866.21	6.02	−0.01	Dominated
No surveillance	1,265,725.43	13,950.12	5.98	−0.05	Dominated